Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in the United States
2012 · Journal of Medical Economics · 17 citations
https://doi.org/10.3111/13696998.2012.749788